Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 15/20 | 0.70 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.68 |
| ▸ | CALCR | P30988 | 3/20 | 0.67 |
| ▸ | CCKBR | P32239 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29939727 | 0.99 | GLP1R (0.72) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL30970990 | 0.98 | GLP1R (0.71) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL29600136 | 0.97 | GLP1R (0.69) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL29499682 | 0.96 | GLP1R (0.70) | GLP1RVIPR1CALCRCCKBR | |
| Aviptadil SCHEMBL30969141 | 0.96 | VIPR1 (0.72) | GLP1RVIPR1CALCRCCKBR | |
| Vasoactive Intestinal Peptide SCHEMBL3041046 | 0.96 | VIPR1 (0.72) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL31182441 | 0.94 | GLP1R (0.66) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL31331832 | 0.94 | VIPR1 (0.68) | GLP1RVIPR1CALCRCCKBR | |
| SCHEMBL29520076 | 0.94 | GLP1R (0.67) | GLP1RCALCRCCKBR | |
| SCHEMBL31139979 | 0.94 | GLP1R (0.66) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240210401-A1 | METHOD OF USING PACAP AND VIP PEPTIDES FOR DETECTING SHED OR CIRCULATING TUMOR CELLS IN BIOLOGICAL FLUIDS | THOMAS JEFFERSON UNIVERSITY | 2024-06-27 | — | — | US | disclosed |
| CN-115066254-A | Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases | 阿德维塔生命科学有限责任公司 | 2022-09-16 | — | — | CN | disclosed |